TRIT1 is a highly conserved tRNA isopentenyl transferase that modifies a subset of tRNAs in human cells and is a candidate tumor suppressor in lung cancer in certain ethnic populations. The yeast homologue, Mod5, has similar tRNA-modifying functions in the cytoplasm and is required for the transcriptional silencing activity of RNA polymerase II promoters near tRNA genes in the nucleus, a phenomenon termed tRNA gene mediated (tgm) silencing. Furthermore, Mod5 can fold into amyloid fibers in vitro and in vivo, which confers resistance to certain fungicides in yeast. Since TRIT1 complements both tRNA modifying and tgm-silencing activities in yeast where the Mod5 gene has been deleted, it seemed possible that TRIT1 might also have amyloid-forming capabilities. Here we show that TRIT1, like Mod5, directly binds to tRNAs that are both substrate and non-substrates for modification with similar affinity, and to an unstructured, non-tRNA. Binding appears to involve distinct protein-RNA multimers which decrease in electrophoretic mobility as the protein to RNA ratio increases. Furthermore, we characterize TRIT1 as a novel human amyloid fiber forming protein. We discuss these data in light of TRIT1's functional roles and possible implications for disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gene.2016.10.041 | DOI Listing |
Alzheimers Dement
December 2024
LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Background: In-vivo PET imaging studies have demonstrated neuroinflammation (microglia reactivity) in the neocortex of Alzheimer's disease (AD) patients. However, the extent and implication of microglia reactivity in white matter regions remains unclear. Here, we explored microglia reactivity in white matter using PET imaging of the translocator protein (TSPO) in relation to core AD biomarkers (amyloid, tau, and astrogliosis), microstructural damage, and cognitive decline.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Munich Cluster for Systems Neurology (SyNergy), Munich, Bavaria, Germany.
Background: In Alzheimer's disease (AD), cortical tau aggregation is a strong predictor of cortical brain atrophy as shown by MRI and PET studies, particularly driving the degeneration of neuronal somata in the grey matter. However, tau's physiological role is to stabilize microtubules within axons in the brain's white matter (WM) pathways. Therefore, tau's white-to-grey-matter translocation and aggregation in neurofibrillary tangles close to neuronal somata may induce WM degeneration through destabilization of axonal microtubule integrity.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Alabama at Birmingham, Birmingham, AL, USA.
Background: The potential of plasma Aβ42/Aβ40 ratio, NfL, p-tau 181, and p-tau 217 has been extensively discussed in the literature. Our previous study explored the association between retinal biomarkers and preclinical AD. The goal of this study was to evaluate the association and a multimodal model of retinal and plasma biomarkers for detection of preclinical AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, University of Southern California, Marina del Rey, CA, USA.
Background: Diffusion MRI (dMRI) metrics of brain microstructure offer valuable insight into Alzheimer's disease (AD) pathology; recent reports have identified dMRI metrics that (1) tightly link with CSF or PET measures of amyloid and tau burden; and (2) mediate the relationship between CSF markers of AD and delayed logical memory performance, commonly impaired in early AD [1,2]. To better localize white matter tract disruption in AD, our BUndle ANalytic (BUAN) [3] tractometry pipeline allows principled use of statistical methods to map factors affecting microstructural metrics along the 3D length of the brain's fiber tracts. Here, we extended BUAN to pool data from multiple scanning protocols/sites - using a new harmonized tractometry approach, based on ComBat [4,5], a widely-used harmonization method modeling variations in multi-site datasets due to site- and scanner-specific effects.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Orsay, France.
Background: Typical Alzheimer's disease (AD) and Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) are two neurodegenerative diseases that present with a similar initial amnestic clinical phenotype but have distinct proteinopathies. AD is characterised by ß-amyloid plaques and intraneuronal neurofibrillary tangles, while LATE is characterised by abnormal neuronal TDP-43 protein. With reference to the prion-like hypothesis regarding the propagation of proteinopathies, investigating white matter fibre bundle alterations could provide new insights into the propagation pathways of specific proteinopathies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!